Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065602

CEO and Chairman sold 49,560 shares at an average $59.88 ($2,967,819)

  • CEO and Chairman acquired 49,560 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS CHAD M CEO and Chairman 2020-12-28 Option exercise +16,250 $0.33 $5,363 1,794,430 D
ROBINS CHAD M CEO and Chairman 2020-12-28 Sale −13,542 $60.71 $822,135 1,780,888 D
ROBINS CHAD M CEO and Chairman 2020-12-28 Sale −1,108 $61.48 $68,120 1,779,780 D
ROBINS CHAD M CEO and Chairman 2020-12-28 Sale −1,500 $62.60 $93,900 1,778,280 D
ROBINS CHAD M CEO and Chairman 2020-12-28 Sale −100 $63.41 $6,341 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-12-29 Option exercise +16,790 $0.33 $5,541 1,794,970 D
ROBINS CHAD M CEO and Chairman 2020-12-29 Sale −8,256 $58.87 $486,031 1,786,714 D
ROBINS CHAD M CEO and Chairman 2020-12-29 Sale −6,834 $59.42 $406,076 1,779,880 D
ROBINS CHAD M CEO and Chairman 2020-12-29 Sale −1,700 $60.73 $103,241 1,778,180 D
ROBINS CHAD M CEO and Chairman 2020-12-30 Option exercise +16,520 $0.33 $5,452 1,794,700 D
ROBINS CHAD M CEO and Chairman 2020-12-30 Sale −7,651 $59.20 $452,939 1,787,049 D
ROBINS CHAD M CEO and Chairman 2020-12-30 Sale −8,869 $59.65 $529,036 1,778,180 D
Derivatives
ROBINS CHAD M CEO and Chairman 2020-12-28 Option exercise · Stock Option (Right to Buy) −16,250 33,310 D
ROBINS CHAD M CEO and Chairman 2020-12-29 Option exercise · Stock Option (Right to Buy) −16,790 16,520 D
ROBINS CHAD M CEO and Chairman 2020-12-30 Option exercise · Stock Option (Right to Buy) −16,520 0 D
Open-market sales · 49,560 sh · avg $59.88 · $2,967,819
Loading xslF345X03/doc4.xml…